Palantir Is Down 6% Today and 40% in 2026. Will It Break Below $100 Next?

Shares of Palantir (NASDAQ:PLTR) banal are down 6% successful Thursday greeting trading, changing hands adjacent $106.50 aft a anterior adjacent of $113.50. The determination drops PLTR banal to its lowest level successful implicit a year, deepening a drawstring of caller 52-week lows.

Zoom retired and the representation is rougher, arsenic Palantir banal is present down astir 40% successful 2026. June is shaping up to beryllium Palantir's worst period connected record.

With PLTR banal present hovering conscionable supra $100, the question everyone is asking is whether the adjacent limb drags Palantir shares done that circular number. It's a genuine unfastened question alternatively than a assured forecast.

No Single Fresh Catalyst, Just a Continuing Derating

There's nary caller header driving today's circumstantial driblet successful Palantir stock. Instead, PLTR is caught successful a broader bundle and AI selloff that immoderate traders person nicknamed the "SaaSpocalypse," a repricing of richly valued bundle names amid fears that AI agents could erode accepted endeavor subscription models. Interest-rate unit connected the bundle radical is adding to the squeeze.

The valuation sits astatine the halfway of the Palantir story. Recent sum cited a trailing P/E ratio adjacent 144x, and different readings enactment Palantir's P/E ratio astatine 160x with a price-to-book ratio of 35x and a free-cash-flow output nether 1%. Numbers similar that permission small country for disappointment erstwhile superior rotates retired of costly software, and Palantir has been astatine the beforehand of that rotation.

Act now: the expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks — and Palantir didn't marque the cut. Grab the names FREE today.

Company-specific overhangs are not helping. Reports bespeak that France's home quality bureau is transitioning disconnected Palantir's tools to home supplier ChapsVision, and the UK National Health Service (NHS) declaration is drafting renewed scrutiny. Both rise questions astir Palantir's planetary public-sector maturation runway.